EVP, Quality & Ethics, and CPL · Emergent BioSolutions Inc. · Common Stock
Side
D
Value
$315K
Shares
28.8K
Price
$10.92
Executed
Feb 6, 2026
Disclosed
Feb 10, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Feb 6 executedFeb 10, 2026 disclosed
EBS · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disposition to issuer — administrative, little informational value
Relative size+15 / 25
$315K reported value · 33.3% of prior position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Glessner Coleen filed this Form 4 reporting a disposition to issuer of EBS on Feb 6, 2026. It became public on Feb 10, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
EVP, Quality & Ethics, and CPL
Glessner Coleencik:0001919170
Issuer
Emergent BioSolutions Inc.cik:0001367644
Revision history · 0
No field has changed since this record was first ingested.
